Accumulate Siemens: Anagram

Published on Thu, Jul 24, 2008 at 12:43 |  Source : Moneycontrol.com

Updated at Fri, Jul 25, 2008 at 11:48  

29974 Investors following Siemens. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

Anagram Research has recommended an accumulate rating on Siemens in its July 23, 2008 research report. "Siemens India (SIL) has announced capex of 100 million euro over next one year. SIL has made this move to bring all the facilities (design, technical assistance, R&D facility) closer to the market as per the needs of the consumer. According to the management major growth drivers are automation, Industrial solution and services business."
 
"SIL is banking on huge investment in Infrastructure sector especially in Power which is expected to increased traction till FY2012, both generation & transmission, Investment in manufacturing, metals etc. At CMP, stock trades at 22.95x FY08E, 15.2X FY09E, 12.5XFY10E earnings, with an EPS of Rs 21.7, Rs 32.8, Rs 39.9 respectively.  We recommend "Accumulate" rating on the stock," says Anagram's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

For further details click on attachment......

Attachments : siemens.pdf

  

More on Moneycontrol

Trending News

Business News

Tech2's Nokia Lumia Contest is Live
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com